Cubist Systematic Strategies’s Immunovant IMVT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.51M | Buy |
94,287
+36,165
| +62% | +$579K | 0.01% | 793 |
|
|
2025
Q1 | $993K | Buy |
+58,122
| New | +$993K | 0.01% | 877 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1872 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1844 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 2002 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 2499 |
|
|
2023
Q4 | – | Sell |
-184,187
| Closed | -$7.07M | – | 2381 |
|
|
2023
Q3 | $7.07M | Buy |
184,187
+104,799
| +132% | +$4.02M | 0.05% | 337 |
|
|
2023
Q2 | $1.51M | Sell |
79,388
-74,431
| -48% | -$1.41M | 0.01% | 1014 |
|
|
2023
Q1 | $2.39M | Buy |
153,819
+68,381
| +80% | +$1.06M | 0.01% | 1019 |
|
|
2022
Q4 | $1.52M | Buy |
85,438
+51,007
| +148% | +$905K | 0.01% | 1483 |
|
|
2022
Q3 | $192K | Buy |
34,431
+6,264
| +22% | +$34.9K | ﹤0.01% | 3008 |
|
|
2022
Q2 | $110K | Sell |
28,167
-11,765
| -29% | -$45.9K | ﹤0.01% | 3405 |
|
|
2022
Q1 | $220K | Sell |
39,932
-28,012
| -41% | -$154K | ﹤0.01% | 2979 |
|
|
2021
Q4 | $579K | Sell |
67,944
-55,658
| -45% | -$474K | 0.01% | 2336 |
|
|
2021
Q3 | $1.07M | Buy |
123,602
+71,669
| +138% | +$623K | 0.01% | 1462 |
|
|
2021
Q2 | $549K | Sell |
51,933
-80,808
| -61% | -$854K | 0.01% | 1944 |
|
|
2021
Q1 | $2.13M | Buy |
132,741
+121,968
| +1,132% | +$1.96M | 0.03% | 996 |
|
|
2020
Q4 | $498K | Sell |
10,773
-13,956
| -56% | -$645K | 0.01% | 1778 |
|
|
2020
Q3 | $870K | Buy |
24,729
+20,240
| +451% | +$712K | 0.01% | 1415 |
|
|
2020
Q2 | $109K | Buy |
4,489
+4,150
| +1,224% | +$101K | ﹤0.01% | 2180 |
|
|
2020
Q1 | $5K | Buy |
+339
| New | +$5K | ﹤0.01% | 2097 |
|